Multiple inducers of endothelial NOS (eNOS) dysfunction in sickle cell disease.

Area of Science:

• Cardiovascular Biology
• Hematology
• Immunology

Background:

• Sickle cell disease (SCD) is characterized by a systemic inflammatory state.
• Endothelial nitric oxide synthase (eNOS) dysfunction is a key feature of this inflammatory state in SCD.

Purpose of the Study:

• To identify specific factors in the sickle cell context that contribute to eNOS dysfunction.
• To evaluate the implications of these factors for clinical assessment of endothelial function and therapeutic strategies.

Main Methods:

• Literature review and analysis of known endothelial cell inputs in the context of sickle cell disease.
• Identification of factors known to cause eNOS dysfunction.
• Simulation of eNOS dysfunction effects on flow-mediated dilation (FMD) testing.

Main Results:

• Ten specific endothelial cell inputs implicated in SCD were identified: endothelial arginase depletion, asymmetric dimethylarginine, complement activation, endothelial glycocalyx degradation, free fatty acids, inflammatory mediators, microparticles, oxidized low-density lipoproteins, reactive oxygen species, and Toll-like receptor 4 signaling ligands.
• Two mechanisms mimicking true eNOS dysfunction (hemoglobin consumption of NO and oxidation of smooth muscle cell soluble guanylate cyclase) can confound flow-mediated dilation (FMD) test interpretations.
• The multiplicity of injurious factors suggests that single-target therapies may be insufficient.

Conclusions:

• Multiple factors contribute to eNOS dysfunction in sickle cell disease, complicating clinical assessments like FMD.
• Therapeutic strategies should aim to protect eNOS function directly or employ combination approaches for efficacy.
• Addressing the complex interplay of these factors is crucial for managing endothelial dysfunction in SCD.